These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11731887)

  • 21. Topiramate: new indication. A bulkier assessment file.
    Prescrire Int; 1999 Oct; 8(43):141-2. PubMed ID: 11503838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Weight loss associated with topiramate treatment].
    Maciá- Bobes C; Cortejoso-García R; Carrio-Montes I; Arias Rodríguez M
    Rev Neurol; 2002 Feb 16-28; 34(4):397. PubMed ID: 12022061
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of topiramate on physical growth during treatment of children with epilepsy].
    Zhou T; Zhang L; Gao JW
    Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):307-8. PubMed ID: 15924733
    [No Abstract]   [Full Text] [Related]  

  • 24. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
    Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P
    Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198
    [No Abstract]   [Full Text] [Related]  

  • 25. Pruritus, a rare but troublesome adverse reaction of topiramate.
    Ochoa JG
    Seizure; 2003 Oct; 12(7):516-8. PubMed ID: 12967582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.
    Jansen JF; Aldenkamp AP; Marian Majoie HJ; Reijs RP; de Krom MC; Hofman PA; Eline Kooi M; Nicolay K; Backes WH
    Epilepsy Behav; 2006 Aug; 9(1):181-5. PubMed ID: 16793345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The occurrence of drug-induced myopia as a transient side effect of topiramate.
    Gubbay SS
    Epilepsia; 1998 Apr; 39(4):451. PubMed ID: 9578038
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment with antiepileptic agents in patients with mental retardation and multiple handicaps].
    Brodtkorb E
    Tidsskr Nor Laegeforen; 2001 Mar; 121(7):834-5. PubMed ID: 11301710
    [No Abstract]   [Full Text] [Related]  

  • 29. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
    Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H
    Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of weight loss in adults with topiramate-treated epilepsy.
    Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U
    Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal hypocalcemic seizures in siblings exposed to topiramate in utero.
    Gorman MP; Soul JS
    Pediatr Neurol; 2007 Apr; 36(4):274-6. PubMed ID: 17437916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of topiramate on serum bicarbonate concentrations in adults.
    Garris SS; Oles KS
    Ann Pharmacother; 2005 Mar; 39(3):424-6. PubMed ID: 15701764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central hyperventilation related to administration of topiramate.
    Laskey AL; Korn DE; Moorjani BI; Patel NC; Tobias JD
    Pediatr Neurol; 2000 Apr; 22(4):305-8. PubMed ID: 10788749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis.
    Pasini A; Pitzianti M; Baratta A; Moavero R; Curatolo P
    Clin Neuropharmacol; 2014; 37(1):38-9. PubMed ID: 24434533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up.
    Lee HW; Jung DK; Suh CK; Kwon SH; Park SP
    Epilepsy Behav; 2006 Jun; 8(4):736-41. PubMed ID: 16647301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin.
    Vossler DG
    Neurology; 1996 Mar; 46(3):852-3. PubMed ID: 8618710
    [No Abstract]   [Full Text] [Related]  

  • 38. [Symptoms of parietal epilepsy probably associated to the use of topiramate in a case of temporal epilepsy].
    Hernán-Pérez Torralba L; Amo C; Alonso-Fernández J; Basurte-Villamor MP
    Rev Neurol; 2005 Nov 1-15; 41(9):574-5. PubMed ID: 16254866
    [No Abstract]   [Full Text] [Related]  

  • 39. [Psychosis following treatment with topiramate].
    Voskuil PH
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):319-20; author reply 320. PubMed ID: 12622013
    [No Abstract]   [Full Text] [Related]  

  • 40. A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice.
    Sankar R; Ramsay E; McKay A; Hulihan J; Wiegand F;
    Epilepsy Behav; 2009 Aug; 15(4):506-12. PubMed ID: 19643672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.